Beijing Life Capital Management Co., Ltd. signed the share transfer agreement to acquire a 5% stake in Qinghai Spring Medicinal Resources Technology Co., Ltd. from Tibet Rongen Technology Co., Ltd. for approximately CNY 200 million.

Beijing Life Capital Management Co., Ltd. signed the share transfer agreement to acquire a 5% stake in Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHSE:600381) from Tibet Rongen Technology Co., Ltd. for approximately CNY 200 million on December 10, 2021. Beijing Life Capital Management will acquire 29,353,200 shares of Qinghai Spring Medicinal Resources Technology Co., Ltd. at a price of CNY 6.7 per share. Post transaction, Tibet Rongen Technology Co., Ltd. will retain 199,115,194 shares representing 33.92% stake in Qinghai Spring Medicinal Resources Technology Co., Ltd.